Items tagged with Advocacy
New pathways for childhood TB treatment: Lessons from the STEP-TB project (post)
TB Alliance and Unitaid released a report, New pathways for childhood TB treatment: Lessons from the STEP-TB project, documenting how the STEP-TB project has reshaped the market for pediatric TB drugs by reducing barriers to entry, engaging in innovative industry collaboration to launch optimized products for children, and mobilizing strong demand. Since launching in 2015, these new medicines have begun to reach children around the world, setting a precedent for future action in the fight to end TB.
Webinar: Engaging policy makers ahead of the Ministerial Conference and UN High-Level Meeting on TB (post)
Treatment Action Group (TAG) and the Global Coalition of TB Activists (GCTA) will host a webinar on 25 October 2017 3:30 PM - 5:00 PM EEST on how civil society and community groups can initiate a dialogue with their national governments in advance of the Global Ministerial Conference on TB in Moscow to be held on 16-17 November 2017. Panelists will debut new, community-developed outreach tools and share strategies to maintain an open channel for communication and accountability in the lead up to the UN High-Level Meeting on TB in 2018 and beyond.
Online training course on challenging intellectual barriers (post)
AIDS & Rights Alliance for Southern Africa (ARASA) are offering an online training course for civil society organizations in Africa. The training will help HIV and health activist groups challenge intellectual property barriers that impede access to affordable medicines.
Now available: Tools to help support activists in engaging national policy makers on TB (post)
Two unprecedented political opportunities are rapidly approaching– the Global Ministerial Conference and the UN High-Level Meeting on TB. Civil society and community groups have a critical role to play in raising the profile and understanding of the issues we face in TB among government officials and ensuring that the commitments they make at high-level meetings are translated into urgent investments and actions.
Personal stories from TB survivors: My journey fighting TB (post)
Tuberculosis (TB) is the world's top infectious killer today. It is airborne and can affect any one of us. Over 5 000 women, men and children still die each day from TB. The social and economic impacts are devastating, including poverty, stigma and discrimination. This disease is curable and preventable, yet global actions and investments fall far short of those needed to end the global TB epidemic.
Reaching for the Stars: Stop TB Partnership announces call for the 2017 Kochon Prize nominations for TB researchers and developers (post)
6 November 2017 – Geneva, Switzerland – Stop TB Partnership is pleased to announce the call for the 2017 Kochon Prize. This year we are celebrating the TB research and development community.
Stop TB Partnership vacancies (post)
The Stop TB Partnership currently has two vacancies available.
Fighting TB stigma: we need to apply lessons learnt from HIV activism (post)
BMJ Global Health published an article on TB stigma and how lessons learnt from HIV activism can be successfully applied to confront the TB-related stigma.
Less than one week to go: First WHO Global Ministerial Conference on Ending TB (post)
75 Ministers, 114 country delegations and over 1000 participants registered
World Antibiotic Awareness Week 13-19 November to draw attention to global AMR threat (post)
World Antibiotic Awareness Week will take place next week from 13-19 November, shining a spotlight on the growing crisis of antimicrobial resistance (AMR). The first descriptions of infectious diseases becoming resistant to the antimicrobial treatments available were in 1948 and were for drugs used to treat tuberculosis (TB).
Page 17 of 127 · Total posts: 0
←First 16 17 18 Last→